Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Blood

Showing results (581-590 of 50,528) with videos related to

Pageof 5,053
Sort By:
Blood|April 6, 2001
The myeloma-associated oncogene fibroblast growth factor receptor 3 is transforming in hematopoietic cellsZ Li, Y X Zhu, E E Plowright, et al.
Blood|April 6, 2001
Activating mutation of D835 within the activation loop of FLT3 in human hematologic malignanciesY Yamamoto, H Kiyoi, Y Nakano, et al.
Blood|April 6, 2001
ARG tyrosine kinase activity is inhibited by STI571K Okuda, E Weisberg, D G Gilliland, et al.
Blood|April 6, 2001
Myeloblastin is an Myb target gene: mechanisms of regulation in myeloid leukemia cells growth-arrested by retinoic acidP G Lutz, A Houzel-Charavel, C Moog-Lutz, et al.
Blood|April 6, 2001
Mac-1 (CD11b/CD18) is essential for Fc receptor-mediated neutrophil cytotoxicity and immunologic synapse formationA B van Spriel, J H Leusen, M van Egmond, et al.
Blood|April 6, 2001
Coexpression of band 3 mutants and Rh polypeptides: differential effects of band 3 on the expression of the Rh complex containing D polypeptide and the Rh complex containing CcEe polypeptideR Beckmann, J S Smythe, D J Anstee, et al.
Blood|April 21, 2001
High response rate in refractory and poor-risk multiple myeloma after allotransplantation using a nonmyeloablative conditioning regimen and donor lymphocyte infusionsA Badros, B Barlogie, C Morris, et al.
Blood|April 21, 2001
Influence of the hematopoietic stem cell source on early immunohematologic reconstitution after allogeneic transplantationV Lapierre, N Oubouzar, A Aupérin, et al.
Blood|April 21, 2001
Ionizing radiation sensitizes erythroleukemic cells but not normal erythroblasts to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)--mediated cytotoxicity by selective up-regulation of TRAIL-R1R Di Pietro, P Secchiero, R Rana, et al.
Blood|April 21, 2001
CrkL is an adapter for Wiskott-Aldrich syndrome protein and SykA Oda, H D Ochs, L A Lasky, et al.
Pageof 5,053

Showing results (581-590 of 50,528) with videos related to

Sort By:
Pageof 5,053
Blood|April 6, 2001
The myeloma-associated oncogene fibroblast growth factor receptor 3 is transforming in hematopoietic cellsZ Li, Y X Zhu, E E Plowright, et al.
Blood|April 6, 2001
Activating mutation of D835 within the activation loop of FLT3 in human hematologic malignanciesY Yamamoto, H Kiyoi, Y Nakano, et al.
Blood|April 6, 2001
ARG tyrosine kinase activity is inhibited by STI571K Okuda, E Weisberg, D G Gilliland, et al.
Blood|April 6, 2001
Myeloblastin is an Myb target gene: mechanisms of regulation in myeloid leukemia cells growth-arrested by retinoic acidP G Lutz, A Houzel-Charavel, C Moog-Lutz, et al.
Blood|April 6, 2001
Mac-1 (CD11b/CD18) is essential for Fc receptor-mediated neutrophil cytotoxicity and immunologic synapse formationA B van Spriel, J H Leusen, M van Egmond, et al.
Blood|April 6, 2001
Coexpression of band 3 mutants and Rh polypeptides: differential effects of band 3 on the expression of the Rh complex containing D polypeptide and the Rh complex containing CcEe polypeptideR Beckmann, J S Smythe, D J Anstee, et al.
Blood|April 21, 2001
High response rate in refractory and poor-risk multiple myeloma after allotransplantation using a nonmyeloablative conditioning regimen and donor lymphocyte infusionsA Badros, B Barlogie, C Morris, et al.
Blood|April 21, 2001
Influence of the hematopoietic stem cell source on early immunohematologic reconstitution after allogeneic transplantationV Lapierre, N Oubouzar, A Aupérin, et al.
Blood|April 21, 2001
Ionizing radiation sensitizes erythroleukemic cells but not normal erythroblasts to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)--mediated cytotoxicity by selective up-regulation of TRAIL-R1R Di Pietro, P Secchiero, R Rana, et al.
Blood|April 21, 2001
CrkL is an adapter for Wiskott-Aldrich syndrome protein and SykA Oda, H D Ochs, L A Lasky, et al.
Pageof 5,053